## Genetics — Top Hits (AF<0.005 or functional evidence)

| GENE | RSID | HGVS | IMPACT | CONSEQUENCE | CLINVAR | GNOMAD_AF | NOTE |
|---|---|---|---|---|---|---|---|
| COMT | rs4680 |  |  |  |  |  | COMT Val158Met (Met lowers COMT activity → higher catecholamines, slower E2 methylation). |
| UGT1A1 | rs887829 |  |  |  |  |  | UGT1A1 *28 tag (reduced glucuronidation → slower E2 clearance). |
| CYP1A2 | rs762551 |  |  |  |  |  | CYP1A2 *1F (higher inducibility; affects E2 hydroxylation). |
| CYP3A4 | rs35599367 |  |  |  |  |  | CYP3A4*22 (reduced hepatic clearance of estrogens). |
| CYP3A5 | rs776746 |  |  |  |  |  | CYP3A5*3 (non-expressor; shifts clearance burden to CYP3A4). |
| CYP19A1 | rs10046 |  |  |  |  |  | CYP19A1 3′UTR variant (associated with E2 levels). |
| CYP19A1 | rs4646 |  |  |  |  |  | CYP19A1 intronic (aromatase regulation). |
| CYP19A1 | rs700519 |  |  |  |  |  | CYP19A1 Arg264Cys (reduced aromatase activity). |
| CYP19A1 | rs727479 |  |  |  |  |  | CYP19A1 intronic (strong LD with E2 variation). |
| SHBG | rs6259 |  |  |  |  |  | SHBG Asp327Asn (↑SHBG, ↓free E2). |

See full appendix for details.
